Frequency of Allergy Shots: Why the Schedule Is What It Is
The frequency of allergy shots is phase-dependent — weekly during the 24–28-week build-up, then every 2–4 weeks during 3–5 years of maintenance per Cox 2011 PP3. The weekly build-up frequency drives Th2-to-Th1/Treg immune shift and IgG4 blocking antibody induction. The 4-week maintenance cap prevents immune tolerance erosion. The 3-year minimum is proven by Durham 1999 (NEJM) and the PAT study (Jacobsen 2007, OR 4.6).
5 peer-reviewed sources
Allergy shot frequency: weekly for 24–28 weeks during build-up, then every 2–4 weeks for 3–5 years during maintenance per Cox 2011 PP3. The 4-week interval cap is not arbitrary — tolerance erodes faster beyond this window.
The essentials
The frequency of allergy shots is phase-dependent — weekly during the 24–28-week build-up, then every 2–4 weeks during 3–5 years of maintenance per Cox 2011 PP3 (Cox L, Nelson H, Lockey R et al., JACI 2011;127(1 Suppl):S1–S55; DOI 10.1016/j.jaci.2010.09.034).
Before committing to the 24–28-week weekly build-up plus 3–5-year maintenance frequency that Cox 2011 PP3 requires, Curex's at-home IgE testing with board-certified allergist review confirms which allergens drive symptoms — and a board-certified allergist determines whether you are a candidate for at-home SCIT self-administration, which follows this same weekly build-up / every-2-to-4-week maintenance schedule at $129/month.
Why is the build-up weekly? The immune tolerance mechanism requires frequent low-dose allergen stimulation to drive the Th2-to-Th1/Treg immune shift: each week's injection presents dendritic cells with the allergen at a slightly higher concentration, progressively inducing allergen-specific regulatory T cells and IgG4-blocking antibodies while avoiding IgE-dependent mast-cell activation. Less frequent stimulation would slow this process and extend the build-up to maintenance; more frequent stimulation would increase the per-injection reaction risk.
Why is the maintenance interval 2–4 weeks, not longer? The 2–4-week maintenance interval is the empirically derived window during which immune tolerance does not meaningfully decay between doses per Cox 2011 PP3. Longer intervals allow the allergen-specific Treg population and IgG4 levels to decline, eroding the immune tolerance accumulated during build-up. The 4-week cap for standardized extracts is a conservative standard — some practices extend to 5–6 weeks during low-symptom seasons as clinician judgment, but this is off-protocol.
Evidence for the 3-year minimum duration: Durham SR et al. (NEJM 1999;341:468–475) documented that 3 years of grass-pollen SCIT in adults produced sustained clinical benefit persisting 3 years after discontinuation — the empirical basis for the 3-year minimum. Shorter courses do not consistently achieve this durable disease-modifying outcome. Pediatric evidence: PAT study 10-year follow-up (Jacobsen L et al., Allergy 2007;62:943–948; DOI 10.1111/j.1398-9995.2007.01451.x) found longitudinal OR 4.6 (95% CI 1.5–13.7) for remaining asthma-free after 3-year pediatric pollen SCIT — also from a 3-year minimum course. The Cochrane meta-analysis (Calderón MA et al., 2007; 51 RCTs, 2,871 patients; SMD −0.73 symptom, SMD −0.57 medication) confirms the cumulative benefit of sustained SCIT across the full course.
The frequency-as-friction issue: build-up translates to approximately 26 injections in the conventional regimen — the largest commitment driver. Tkacz JP et al. (Curr Med Res Opin 2021;37(6):957–965; DOI 10.1080/03007995.2021.1903848): 23.9% of 103,207 SCIT initiators never returned after the first injection; only 43.9% reached maintenance. The weekly build-up frequency is the single largest predictor of dropout.
Cluster (Tabar AI et al., JACI 2005) compresses build-up to 4–8 weeks with 2–3 injections per visit on non-consecutive days — reducing total visit count but increasing per-visit injection count. Rush (Bernstein DI et al., JACI 2008) reaches maintenance in 1–3 days with 5–15% systemic reaction rates — maximum time compression, maximum clinical intensity.
FDA-approved SLIT tablets (Grastek, Oralair, Ragwitek, Odactra) achieve tolerance induction through a completely different frequency model: once-daily oral administration. The daily frequency allows cumulative tolerance induction through high-frequency very-low-dose stimulation rather than the weekly high-dose SCIT approach. After a supervised first dose, all subsequent SLIT doses are taken at home with no clinic visit required.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youFrequently asked questions
Why do allergy shots have to be so frequent at the start?
Allergy shots are weekly during the build-up phase because the immunological mechanism of SCIT requires frequent low-dose allergen stimulation to drive the immune shift from IgE-dominated Th2 reactivity toward allergen-specific regulatory T cells and IgG4-blocking antibodies. Per Cox 2011 PP3, the weekly interval provides enough stimulation to advance the dilution ladder while limiting the risk of systemic reactions — each dose is small enough relative to the previous step that the immune system adapts rather than reacts. Less frequent build-up would significantly extend the time to reach maintenance dose and the therapeutic clinical benefit.
Is it safe to space out allergy shots to every month during build-up?
Monthly build-up injections are not standard practice and would substantially extend the conventional 24–28-week build-up to more than a year. The Cox 2011 PP3 conventional build-up is specifically designed as a weekly schedule because the dose-escalation steps require close immunological monitoring and the weekly dose increases are calibrated for weekly administration intervals. Some cluster protocols use 2–3 visits per week to compress build-up further in the opposite direction. If monthly build-up were attempted, the allergist would likely need to repeat doses or slow the advancement rate to account for the extended intervals, negating the benefit of the faster schedule.
Can allergy shots be spaced further apart during maintenance?
Cox 2011 PP3 specifies a maximum maintenance interval of 4 weeks for standardized allergen extracts, because longer intervals risk erosion of the immune tolerance accumulated during build-up — the allergen-specific regulatory T cells and IgG4-blocking antibody levels that underpin tolerance induction decline during extended gaps. Some practices extend to 5–6 weeks during low-allergen seasons as clinician judgment, but this is off-protocol per Cox 2011 PP3. Extending maintenance intervals beyond 4 weeks may reduce the cumulative benefit of the full 3–5-year course and is generally not recommended without allergist assessment.
How long do you need allergy shots before they stop working if you quit?
The minimum SCIT course for durable post-treatment benefit is 3 years, per the foundational evidence from Durham SR et al. (NEJM 1999;341:468–475) — 3 years of grass-pollen SCIT produced sustained clinical benefit persisting at least 3 years after discontinuation in adults. The pediatric PAT study (Jacobsen L et al., Allergy 2007) documented 10-year asthma-prevention benefit after a 3-year course. Patients who discontinue before 3 years may retain partial benefit but are unlikely to achieve the full disease-modifying remission documented in these trials. Tkacz 2021 found that 23.9% of adults never returned after the first injection — these patients receive no clinical benefit at all.
Do allergy shots work faster with more frequent injections?
Cluster immunotherapy — which delivers 2–3 injections per visit on multiple days per week — compresses the build-up phase from 24–28 weeks to 4–8 weeks and reaches maintenance faster. This earlier maintenance arrival may translate to earlier clinical benefit, per Tabar AI et al. (JACI 2005;116:109–18). However, rush immunotherapy, which reaches maintenance in 1–3 days through even more intensive dosing, carries 5–15% systemic reaction rates (Bernstein DI et al., JACI 2008) — meaning more frequency comes with substantially higher risk. Neither accelerated protocol shortens the maintenance phase: the 3–5-year maintenance requirement and its every-2-to-4-week frequency remain unchanged regardless of how quickly build-up was completed.
What is the difference between cluster and conventional allergy shot frequency?
Conventional allergy shot build-up involves one injection per week over 24–28 weeks, reaching maintenance after approximately 24–28 total injections. Cluster build-up delivers 2–3 injections per visit day on non-consecutive visit days (typically 2–3 days per week), reaching the same maintenance dose in 4–8 weeks — substantially fewer calendar weeks than conventional, though with more injections per visit day. Cluster protocols were established by Tabar AI et al. (JACI 2005;116:109–18) and require premedication (antihistamine, leukotriene inhibitor) before each cluster visit day. The maintenance phase frequency (every 2–4 weeks for 3–5 years) is identical after either type of build-up.
Related Articles
Allergy Shot Frequency: Phase-by-Phase Guide | Curex
Allergy shot frequency: weekly during 24–28-week build-up, then every 2–4 weeks during 3–5-year maintenance per Cox 2011 PP3. Cluster and rush variants explained.
Read moreAllergy Shot Dose Schedule: Dilution Ladder Guide | Curex
Allergy shot dose schedule: 5–6-vial dilution ladder, 1:10,000 to 1:1 over 24–28 weeks (Cox 2011 PP3). Vial colors, dose targets, modification protocols.
Read moreAllergy Shot Schedule: Full Timeline Guide | Curex
Allergy shot schedule: weekly build-up 24–28 wks, maintenance every 2–4 wks × 3–5 yrs (Cox 2011). Cluster, rush variants and at-home option explained.
Read moreAllergy Immunotherapy Guide: All Options Compared | Curex
Allergy immunotherapy covers shots, tablets, drops, and OIT. Compare SCIT vs SLIT on efficacy, safety, cost, and FDA status to choose the right route.
Read moreAllergy Therapy: All Treatments Explained | Curex
Allergy therapy spans pharmacotherapy, SCIT shots, SLIT drops, and biologics. Only SCIT and SLIT modify the underlying disease. Learn which therapy fits your situation.
Read moreAre Allergy Shots Effective? | Curex Guide
Are allergy shots effective? Cochrane meta-analysis of 51 RCTs (n=2,871) found symptom SMD −0.73. Per-allergen rates: venom 95%+, grass 80%, cat 62%. Full evidence.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.